El benznidazol no disminuye el riesgo de muerte ni la progresión clínica de enfermedad cardíaca por Chagas crónico

Sguassero, Yanina

El benznidazol no disminuye el riesgo de muerte ni la progresión clínica de enfermedad cardíaca por Chagas crónico / Benznidazole does not decrease the risk of death or clinical progression of chronic Chagas heart disease

Sguassero, Yanina.

Sguassero, Yanina; Centro Rosarino de Estudios Perinatales. Rosario. AR

Evid. actual. práct. ambul ; 19(3): 82-82, 2016.

Article in Spanish | LILACS | ID: biblio-1152161

Subject(s)

Humans; Male; Female; Adult; Middle Aged; Aged; Young Adult; Trypanocidal Agents/therapeutic use; Cardiovascular Diseases/drug therapy; Nitroimidazoles/therapeutic use; Trypanocidal Agents/adverse effects; Trypanosoma cruzi/isolation & purification; Trypanosoma cruzi/genetics; Cardiovascular Diseases/complications; Cardiovascular Diseases/etiology; Cardiovascular Diseases/mortality; Randomized Controlled Trials as Topic; Polymerase Chain Reaction; Chronic Disease; Treatment Failure; Disease Progression; Parasite Load; Genotype; Nitroimidazoles/adverse effects

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Trypanocidal Agents / Cardiovascular Diseases / Nitroimidazoles Type of study: Controlled clinical trial / Etiology study / Risk factors Limits: Adult / Aged / Female / Humans / Male Language: Spanish Journal: Evid. actual. práct. ambul Journal subject: Medicine / Delivery of Health Care Year: 2016 Type: Article Affiliation country: Argentina Institution/Affiliation country: Centro Rosarino de Estudios Perinatales/AR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google